InsiderClue
Insiders · Profile

Novo Holdings A/S

10% owner at Avalyn Pharma · 10% owner at MapLight Therapeutics · 10% owner at SPRUCE BIOSCIENCES · and 16 more. Filing since 20 Feb 2014. CIK 0001388325

AVLN Avalyn Pharma Inc. 10% owner · 1 trade MPLT MapLight Therapeutics, Inc. 10% owner · 1 trade SPRB SPRUCE BIOSCIENCES, INC. 10% owner · 8 trades MGX Metagenomi Therapeutics, Inc. 10% owner · 2 trades IRON Disc Medicine, Inc. 10% owner · 1 trade OKUR OnKure Therapeutics, Inc. 10% owner · 2 trades EWTX Edgewise Therapeutics, Inc. 10% owner · 2 trades BOLT Bolt Biotherapeutics, Inc. 10% owner · 2 trades INGN Inogen Inc 10% owner · 4 trades DMRA Damora Therapeutics, Inc. 10% owner · 1 trade ALGS Aligos Therapeutics, Inc. 10% owner · 1 trade HRMY Harmony Biosciences Holdings, Inc. 10% owner · 1 trade NKTX Nkarta, Inc. 10% owner · 1 trade CRVS Corvus Pharmaceuticals, Inc. 10% owner · 9 trades MIST Milestone Pharmaceuticals Inc. 10% owner · 2 trades MIRM Mirum Pharmaceuticals, Inc. 10% owner · 1 trade ANAB ANAPTYSBIO, INC 10% owner · 9 trades IRTC iRhythm Holdings, Inc. 10% owner · 1 trade AKBA Akebia Therapeutics, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
AVLN Avalyn Pharma Inc.
1 May 2026
10% owner
Bought
555,555
$10.00M
16.7%
MPLT MapLight Therapeutics, Inc.
28 Oct 2025
10% owner
Bought
952,941
$16.20M
34.9%
SPRB SPRUCE BIOSCIENCES, INC.
21 Mar 2024
10% owner
Sold at will
465,021
$350.95K
15.4%
SPRB SPRUCE BIOSCIENCES, INC.
20 Mar 2024
10% owner
Sold at will
359,979
$264.08K
10.7%
SPRB SPRUCE BIOSCIENCES, INC.
19 Mar 2024
10% owner
Sold at will
593,000
$447.72K
14.9%
SPRB SPRUCE BIOSCIENCES, INC.
18 Mar 2024
10% owner
Sold at will
842,020
$647.01K
17.5%
SPRB SPRUCE BIOSCIENCES, INC.
14 Mar 2024
10% owner
Sold at will
1,912,316
$1.70M
28.4%
MGX Metagenomi Therapeutics, Inc.
13 Feb 2024
10% owner
Bought
800,000
$12.00M
85.2%
MGX Metagenomi Therapeutics, Inc.
9 Feb 2024
10% owner
Bought
100,000
$1.03M
opened
IRON Disc Medicine, Inc.
28 Jun 2023
10% owner
Sold at will
1,250,000
$57.63M
53.4%
OKUR OnKure Therapeutics, Inc.
23 Jun 2023
10% owner
Sold at will
100,000
$709.74K
2.9%
SPRB SPRUCE BIOSCIENCES, INC.
16 Feb 2023
10% owner
Bought
2,208,000
$7.00M
48.9%
EWTX Edgewise Therapeutics, Inc.
14 Sep 2022
10% owner
Bought
484,496
$5.00M
8.7%
BOLT Bolt Biotherapeutics, Inc.
13 Jul 2022
10% owner
Sold, plan not stated
800,000
$1.60M
17.8%
INGN Inogen Inc
2 Jun 2021
10% owner
Sold, plan not stated
680,000
$38.98M
24.6%
SPRB SPRUCE BIOSCIENCES, INC.
19 May 2021
10% owner
Sold, plan not stated
475,000
$6.60M
9.5%
OKUR OnKure Therapeutics, Inc.
13 Apr 2021
10% owner
Bought
666,666
$10.00M
24.1%
EWTX Edgewise Therapeutics, Inc.
30 Mar 2021
10% owner
Bought
625,000
$10.00M
12.6%
INGN Inogen Inc
1 Mar 2021
10% owner
Sold, plan not stated
790,000
$38.71M
22.3%
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
10% owner
Bought
400,000
$8.00M
9.7%
DMRA Damora Therapeutics, Inc.
2 Nov 2020
10% owner
Bought
333,333
$5.00M
15.4%
ALGS Aligos Therapeutics, Inc.
20 Oct 2020
10% owner
Bought
200,000
$3.00M
8.3%
SPRB SPRUCE BIOSCIENCES, INC.
14 Oct 2020
10% owner
Bought
250,000
$3.75M
5.3%
HRMY Harmony Biosciences Holdings, Inc.
21 Aug 2020
10% owner
Bought
132,503
$3.18M
3.1%
NKTX Nkarta, Inc.
14 Jul 2020
10% owner
Bought
555,555
$10.00M
24.8%
CRVS Corvus Pharmaceuticals, Inc.
8 Jul 2020
10% owner
Sold, plan not stated
741,440
$3.99M
34.8%
CRVS Corvus Pharmaceuticals, Inc.
7 Jul 2020
10% owner
Sold, plan not stated
796,622
$4.18M
27.2%
MIST Milestone Pharmaceuticals Inc.
25 Nov 2019
10% owner
Sold, plan not stated
240,000
$3.84M
9.0%
CRVS Corvus Pharmaceuticals, Inc.
25 Jul 2019
10% owner
Sold, plan not stated
1,400,000
$5.60M
32.4%
CRVS Corvus Pharmaceuticals, Inc.
24 Jul 2019
10% owner
Sold, plan not stated
53,240
$266.71K
1.2%
CRVS Corvus Pharmaceuticals, Inc.
23 Jul 2019
10% owner
Sold, plan not stated
39,716
$211.13K
0.9%
MIRM Mirum Pharmaceuticals, Inc.
22 Jul 2019
10% owner
Bought
575,000
$8.63M
30.7%
MIST Milestone Pharmaceuticals Inc.
13 May 2019
10% owner
Bought
333,333
$5.00M
14.2%
CRVS Corvus Pharmaceuticals, Inc.
12 Mar 2018
10% owner
Bought
1,176,470
$10.00M
36.3%
ANAB ANAPTYSBIO, INC
21 Aug 2017
10% owner
Sold, plan not stated
356,300
$7.52M
15.5%
ANAB ANAPTYSBIO, INC
15 Aug 2017
10% owner
Sold, plan not stated
143,428
$3.01M
5.9%
ANAB ANAPTYSBIO, INC
14 Aug 2017
10% owner
Sold, plan not stated
35,172
$766.49K
1.4%
ANAB ANAPTYSBIO, INC
7 Aug 2017
10% owner
Sold, plan not stated
481,023
$10.15M
16.3%
ANAB ANAPTYSBIO, INC
4 Aug 2017
10% owner
Sold, plan not stated
10,271
$225.96K
0.3%
ANAB ANAPTYSBIO, INC
3 Aug 2017
10% owner
Sold, plan not stated
21,451
$472.19K
0.7%
ANAB ANAPTYSBIO, INC
2 Aug 2017
10% owner
Sold, plan not stated
25,700
$613.48K
0.9%
ANAB ANAPTYSBIO, INC
1 Aug 2017
10% owner
Sold, plan not stated
23,555
$562.27K
0.8%
CRVS Corvus Pharmaceuticals, Inc.
23 Jun 2017
10% owner
Bought
20,000
$219.00K
0.6%
ANAB ANAPTYSBIO, INC
31 Jan 2017
10% owner
Bought
50,000
$750.00K
1.7%
IRTC iRhythm Holdings, Inc.
25 Oct 2016
10% owner
Bought
100,000
$1.70M
4.9%
CRVS Corvus Pharmaceuticals, Inc.
12 May 2016
10% owner
Bought
70,000
$700.00K
2.2%
CRVS Corvus Pharmaceuticals, Inc.
29 Mar 2016
10% owner
Bought
666,666
$10.00M
26.8%
INGN Inogen Inc
4 Nov 2014
10% owner
Sold, plan not stated
2,000,000
$43.00M
36.0%
AKBA Akebia Therapeutics, Inc.
25 Mar 2014
10% owner
Bought
182,590
$3.10M
13.7%
INGN Inogen Inc
20 Feb 2014
10% owner
Sold, plan not stated
617,000
$9.18M
10.2%
50 decisions on file.